EDO TOKYO TIMELESS EXHIBITION Decided to Be Held

27.2.2025 10:00:00 CET | Business Wire | Press Release

From Friday, March 7 to Sunday, March 9, 2025, Tokyo Metropolis will hold the “Edo Tokyo Kirari Project’s EDO TOKYO TIMELESS Exhibition: Encountering Tokyo’s Time-Honored Brands at Wakeijuku” at Wakeijuku in Bunkyo-ku, famed as the former residence of Marquis Hosokawa.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250225947789/en/

Exhibition Catalogue: “Edo Tokyo Kirari Project’s EDO TOKYO TIMELESS Exhibition: Encountering Tokyo’s Time-Honored Brands at Wakeijuku” (Graphic: Business Wire)

Tokyo Metropolis has implemented the Edo Tokyo Kirari Project, based on the concept of “Old meets New,” to hone the traditional skills, products of long-established shops, and so on throughout Edo-Tokyo from new perspectives and to spread their value and appeal in Japan and overseas as a brand that represents Tokyo.

This time, we will hold a hands-on exhibition to have many people learn about this project furthermore. This exhibition will see 39 model businesses participate, each offering the value and appeal of historical, traditional industries in new forms. We will exhibit each model business’s techniques and products to allow visitors to see and experience in person the traditional skills of food, clothing, and shelter that Edo-Tokyo boasts to the world. In addition, we will offer workshops where visitors can experience and enjoy each business’s techniques, such as Kumiko woodcraft and Kumihimo braiding. The exhibition will also feature special products created in collaboration with Parisian designers, which were exhibited at the French international trade fair Maison&Objet Paris. Enjoy traditions beloved and passed down over the ages, from Edo to Tokyo, from various perspectives. Please see our special article for details about the event.
https://en.edotokyokirari.jp/news/life/edotokyotimeless/

Event Overview
Name:	Edo Tokyo Kirari Project’s EDO TOKYO TIMELESS Exhibition:
	Encountering Tokyo’s Time-Honored Brands at Wakeijuku
Dates and times:	10:00 - 17:00, Friday, March 7 to Sunday, March 9, 2025
	*10:00 to 16:00 on the last day only.
Venue:	Wakeijuku Honkan (former Marquis Hosokawa residence)
	1-21-2 Mejirodai, Bunkyo-ku, Tokyo, 112- 8682
	*No parking is available, so please do not come by car.
Admission:	Free (costs apply to joining the workshops, etc.)
Organizers:	Tokyo Metropolis, Edo Tokyo Kirari Project
Details:	Displays, workshops, sales, etc., related to the techniques and products of Edo Kirari Project model businesses

Overview of the Edo Tokyo Kirari Project & Links

Website: https://en.edotokyokirari.jp/
Special article on exhibition: https://en.edotokyokirari.jp/news/life/edotokyotimeless/
Instagram: https://www.instagram.com/edo_tokyo_kirari
Facebook: https://www.facebook.com/Edo-tokyo-kirari-638579083261624

Overview of Wakeijuku
Wakeijuku Honkan (former Marquis Hosokawa residence) is a typical early Showa-era mansion of Kazoku (Japanese peerage). It was built in 1936 by Marquis Moritatsu Hosokawa, the 16th head of the family. In 1955, Kisaku Maekawa purchased the former Marquis Hosokawa house and its over-23,000 m² estate from the family and established a male students’ dormitory called Wakeijuku within the grounds. Aside from once or twice a month, the grounds are normally closed to the public, but they will be open during this three-day event.

Wakeijuku Honkan (former Marquis Hosokawa residence) Official Site
https://www.wakei.org/honkan/index.html

View source version on businesswire.com: https://www.businesswire.com/news/home/20250225947789/en/

Contacts

Inquiries about the Edo Tokyo Kirari Project
Planning and Coordination Section, General Affairs Division, Bureau of
Industrial and Labor Affairs, Tokyo Metropolitan Government
2-8-1 Nishishinjuku, Shinjuku-ku, Tokyo Japan 163-8001
Tel: +81-3-5320-4685
E-mail: S0290106@section.metro.tokyo.jp

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Presents New Data on ALYFTREK ® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating the long-term safety and efficacy profile of the medicine. The data, presented at the European Cystic Fibrosis Conference, show children ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including those who are homozygous for the F508del mutation (F/F) and those who have F508del/minimal function mutations (F/MF)on ALYFTREK had further improvement in CFTR function from a TRIKAFTA ® baseline as measured by sweat chloride (SwCl), with 65% having achieved SwCl <30 mmol/L after treatment with ALYFTREK. Vertex also presented Phase 3 data of children ages 1 to <2 with TRIKAF

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press Release

Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built

DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press Release

DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press Release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict

Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press Release

A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal opportunities across the Group’s production sites and communities. These are just some of the “sustainability” stories the Barilla Group is sharing on World Environment Day with the publication of its 2025 Sustainability Report. The report comes just after Barilla was named the world’s most reputable company in the food sector for the third year running and, for the first time, ranked among the global top 10 in the Global RepTrak 100 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603162436/en/ “The future of the planet will increasingly depend on our ability to spread culture and education,” says Paolo Barilla, Vic

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom